|Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results|
CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ...
Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008
|A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa|
O Rascol, DJ Brooks, AD Korczyn, PP De Deyn, CE Clarke, AE Lang
New England Journal of Medicine 342 (20), 1484-1491, 2000
|Association between early-onset Parkinson's disease and mutations in the parkin gene|
CB Lücking, A Dürr, V Bonifati, J Vaughan, G De Michele, T Gasser, ...
New England Journal of Medicine 342 (21), 1560-1567, 2000
|Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on …|
CG Goetz, W Poewe, O Rascol, C Sampaio, GT Stebbins, C Counsell, ...
Movement disorders 19 (9), 1020-1028, 2004
|Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan|
CG Goetz, S Fahn, P Martinez‐Martin, W Poewe, C Sampaio, GT Stebbins, ...
Movement disorders 22 (1), 41-47, 2007
|Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL‐PET study|
AL Whone, RL Watts, AJ Stoessl, M Davis, S Reske, C Nahmias, AE Lang, ...
Annals of neurology 54 (1), 93-101, 2003
|A double-blind, delayed-start trial of rasagiline in Parkinson's disease|
CW Olanow, O Rascol, R Hauser, PD Feigin, J Jankovic, A Lang, ...
New England Journal of Medicine 361 (13), 1268-1278, 2009
|The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease|
K Seppi, D Weintraub, M Coelho, S Perez‐Lloret, SH Fox, ...
Movement Disorders 26 (S3), S42-S80, 2011
|The unified Parkinson's disease rating scale (UPDRS): status and recommendations|
Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease
Movement Disorders 18 (7), 738-750, 2003
|Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily …|
O Rascol, DJ Brooks, E Melamed, W Oertel, W Poewe, F Stocchi, ...
The lancet 365 (9463), 947-954, 2005
|Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study|
U Sabatini, K Boulanouar, N Fabre, F Martin, C Carel, C Colonnese, ...
Brain 123 (2), 394-403, 2000
|Depression rating scales in Parkinson's disease: critique and recommendations|
A Schrag, P Barone, RG Brown, AFG Leentjens, WM McDonald, ...
Movement disorders 22 (8), 1077-1092, 2007
|The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease|
SH Fox, R Katzenschlager, SY Lim, B Ravina, K Seppi, M Coelho, ...
Movement Disorders 26 (S3), S2-S41, 2011
|Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial|
P Barone, W Poewe, S Albrecht, C Debieuvre, D Massey, O Rascol, ...
The Lancet Neurology 9 (6), 573-580, 2010
|Evidence‐based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004|
CG Goetz, W Poewe, O Rascol, C Sampaio
Movement disorders: official journal of the Movement Disorder Society 20 (5 …, 2005
|Levodopa in the treatment of Parkinson's disease: current controversies|
CW Olanow, Y Agid, Y Mizuno, A Albanese, U Bonucelli, P Damier, ...
Movement disorders 19 (9), 997-1005, 2004
|Priorities in Parkinson's disease research|
WG Meissner, M Frasier, T Gasser, CG Goetz, A Lozano, P Piccini, ...
Nature reviews Drug discovery 10 (5), 377-393, 2011
|Development and validation of the unified multiple system atrophy rating scale (UMSARS)|
GK Wenning, F Tison, K Seppi, C Sampaio, A Diem, F Yekhlef, I Ghorayeb, ...
Movement Disorders 19 (12), 1391-1402, 2004
|Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke|
J Pariente, I Loubinoux, C Carel, JF Albucher, A Leger, C Manelfe, ...
Annals of neurology 50 (6), 718-729, 2001
|Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder …|
M Horstink, E Tolosa, U Bonuccelli, G Deuschl, A Friedman, P Kanovsky, ...
European journal of neurology 13 (11), 1186-1202, 2006